Article

Holzer retiring: OMIC picks Padovese as new chief executive

San Francisco-Ophthalmic Mutual Insurance Co. (OMIC) has selected Timothy J. Padovese, a senior executive with Norcal Mutual Insurance Co., as its new chief executive officer.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
Related Content
Nicox announces last patient completed final visit in Whistler Phase 3b clinical trial
March 24th 2025

Nicox announces last patient completed final visit in Whistler Phase 3b clinical trial

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Bausch + Lomb publishes results from phase 4 study evaluating patient-reported outcomes with Miebo in dry eye disease
March 24th 2025

Bausch + Lomb publishes results from phase 4 study evaluating patient-reported outcomes with Miebo in dry eye disease

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Study finds cannabis users face higher risk of Thyroid Eye Disease
March 24th 2025

Study finds cannabis users face higher risk of Thyroid Eye Disease

Glaucoma Research Foundation announces 2025 recipients of Shaffer Research Grants
March 23rd 2025

Glaucoma Research Foundation announces 2025 recipients of Shaffer Research Grants

© 2025 MJH Life Sciences

All rights reserved.